SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 130 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,065,000 | +35.5% | 477,621 | +76.2% | 1.44% | +58.4% |
| Q3 2017 | $786,000 | -52.6% | 271,102 | -27.3% | 0.91% | -53.6% |
| Q2 2017 | $1,658,000 | -67.4% | 372,694 | -65.9% | 1.97% | -72.3% |
| Q1 2017 | $5,088,000 | +50.5% | 1,091,768 | +96.7% | 7.09% | +12.9% |
| Q4 2016 | $3,380,000 | +80.9% | 555,085 | +63.7% | 6.28% | +93.5% |
| Q3 2016 | $1,868,000 | +64.9% | 339,068 | +13.7% | 3.25% | +56.5% |
| Q2 2016 | $1,133,000 | -34.1% | 298,190 | -1.6% | 2.08% | -20.1% |
| Q4 2015 | $1,719,000 | +59.6% | 303,157 | +49.2% | 2.60% | +8.3% |
| Q3 2015 | $1,077,000 | – | 203,155 | – | 2.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
| DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
| Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
| WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
| EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
| CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
| Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
| Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |